Similar articles

• Thymosin in cancer patients: in vitro effects and correlations with clinical response to thymosin immunotherapy.

  Chretien PB, Lipson SD, Makuch R, Kenady DE, Cohen MH, Minna JD. Chretien PB, et al. Cancer Treat Rep. 1978 Nov;62(11):1787-90. Cancer Treat Rep. 1978. PMID: 215307 Clinical Trial.
• Thymosin reconstitution of T cell deficits in vitro in cancer patients.

  Kenady DE, Chretien PB, Potvin C, Simon RM. Kenady DE, et al. Cancer. 1977 Feb;39(2):575-80. doi: 10.1002/1097-0142(197702)39:2<575::aid-cncr2820390230>3.0.co;2-q. Cancer. 1977. PMID: 300039
• [In vitro effect of calf thymosin on T cell of cancer patients].

  Ye M. Ye M. Zhonghua Zhong Liu Za Zhi. 1982 Nov;4(4):245-8. Zhonghua Zhong Liu Za Zhi. 1982. PMID: 6984676 Chinese. No abstract available.
• Thymosin: basic properties and clinical potential in the treatment of patients with immunodeficiency diseases and cancer.

  Goldstein AL. Goldstein AL. Antibiot Chemother (1971). 1978;24:47-59. doi: 10.1159/000401500. Antibiot Chemother (1971). 1978. PMID: 350140 Review. No abstract available.
• [Cell mediated immunity in lung cancer].

  Szczepaniec M. Szczepaniec M. Folia Med Cracov. 1979;21(1):49-72. Folia Med Cracov. 1979. PMID: 396193 Review. Polish. No abstract available.